Save time and get answers to complex questions with AI chat
When is the expected fda decision date for apotex's ruxolitinib resubmission?Can wine consumption affect lipitor's cholesterol lowering ability?Combivent inhaler hfc 152a patents?Are there specific stretches to avoid while on lipitor?Xiaflex market launch year?
See the DrugPatentWatch profile for verzenio
Verzenio (active ingredient: abemaciclib) is a branded oral cancer medicine and has not been listed in the provided information as having an approved generic alternative.
Whether a generic exists depends on patent/exclusivity status and whether regulators have approved an alternative product. For Verzenio specifically, branded exclusivity and related intellectual property can delay generic entry until those protections expire. DrugPatentWatch tracks patent and exclusivity information for drugs, including whether and when competitors (like generics) might be expected. You can check Verzenio’s status there: https://www.drugpatentwatch.com/ (search for “Verzenio/abemaciclib”).
If you’re trying to find a lower-cost alternative, the most practical next steps are: - Ask your oncologist or pharmacist whether any approved generic abemaciclib is available in your country. - If not, ask about therapeutic alternatives (other CDK4/6 inhibitors) that your regimen could substitute, depending on your cancer type and prior treatments.
If an approved generic abemaciclib is available, it would have a market authorization under that specific country’s regulator. Without confirmed availability details from the provided sources, the manufacturer and product name can’t be verified here. Sources: 1. https://www.drugpatentwatch.com/
Other Questions About Verzenio :